Spirometry Results Guide: Understanding Lung Test Results

”

According to the American Thoracic Society, spirometry is the most important and widely used pulmonary function test, with key measurements including FEV1, FVC, and the FEV1/FVC ratio providing essential information for diagnosing and managing asthma, COPD, and other respiratory conditions.

FVC - Forced Vital Capacity

FVC is the total amount of air you can forcefully exhale after taking the deepest breath possible.

What it measures:

• Total lung capacity: How much air your lungs can hold and exhale
• Restrictive disease: Reduced lung capacity
• Obstructive disease: May be reduced if air trapping present

Normal FVC:

• ≥80% of predicted value (based on age, height, sex, race)
• Predicted values: Based on population studies
• Variability: Normal range is usually 80-120% of predicted

Abnormal FVC:

• <80% predicted: Suggests restrictive pattern
• Causes: Pulmonary fibrosis, chest wall disease, neuromuscular weakness

FEV1 - Forced Expiratory Volume in 1 Second

FEV1 is the amount of air you can forcefully exhale in one second.

What it measures:

• Airflow speed: How quickly you can exhale air
• Obstructive disease: Reduced FEV1 is hallmark of obstruction
• Severity: Used to grade asthma and COPD severity

Normal FEV1:

• ≥80% of predicted value
• Depends on: Age, height, sex, race
• Normal variation: 80-120% of predicted

Abnormal FEV1:

• <80% predicted: Suggests obstructive or restrictive disease
• Severity classification: Based on how reduced FEV1 is
• Monitoring: Serial FEV1 measurements track disease progression

FEV1/FVC Ratio

FEV1/FVC ratio is the proportion of air you can exhale in the first second compared to the total amount you exhale.

What it measures:

• Obstruction: Ratio <0.70 indicates airway obstruction
• Distinguishes: Obstructive vs. restrictive pattern
• Diagnostic criterion: For COPD (FEV1/FVC <0.70 post-bronchodilator)

Normal FEV1/FVC:

• ≥0.70 (70%): Normal ratio
• Usually >0.75: In younger adults
• Declines slightly: With normal aging

Abnormal FEV1/FVC:

• <0.70: Suggests obstructive lung disease
• Asthma or COPD: Most common causes
• Reversible: In asthma (improves with bronchodilator)
• Fixed: In COPD (little improvement with bronchodilator)

PEF - Peak Expiratory Flow

PEF is the maximum speed at which you can exhale air.

What it measures:

• Airway patency: How open airways are
• Diurnal variation: Morning vs. evening differences
• Asthma monitoring: Home PEF monitoring

Normal PEF:

• ≥80% of predicted (or personal best)
• Personal best: Better than predicted values
• Variation: <20% diurnal variation normal

Abnormal PEF:

• <80%: Suggests airway narrowing
• Asthma: Typically reduced with symptoms
• Improvement: With bronchodilator

Normal Spirometry Pattern

Normal results:

• FVC: ≥80% predicted
• FEV1: ≥80% predicted
• FEV1/FVC: ≥0.70

What normal means:

• No significant lung disease: Lungs functioning normally
• Airways open: No obstruction
• Lungs full size: No restriction
• Good effort: Test performed properly

But normal spirometry doesn't rule out all lung disease:

• Asthma: May be normal between symptoms
• Early lung disease: May not show on spirometry
• Extra-pulmonary: May have other causes of symptoms

Obstructive Spirometry Pattern

Obstructive pattern:

• FEV1/FVC: <0.70 (reduced ratio)
• FEV1: <80% predicted (usually)
• FVC: May be normal or reduced
• Reversibility: May improve with bronchodilator

Common obstructive diseases:

Asthma:

• Reversible obstruction: FEV1 improves ≥12% and ≥200 mL after bronchodilator
• Variable: Normal between symptoms, abnormal during
• Airway hyperresponsiveness: Bronchoprovocation positive

COPD:

• Fixed obstruction: Little improvement with bronchodilator
• FEV1/FVC <0.70: Diagnostic criterion
• Staged by FEV1: Severity based on post-bronchodilator FEV1
• Progressive: FEV1 declines over time

Bronchiectasis:

• Obstructive pattern: Similar to COPD
• Production: Chronic sputum production
• CT diagnosis: Confirmed with imaging

Restrictive Spirometry Pattern

Restrictive pattern:

• FVC: <80% predicted (reduced)
• FEV1: <80% predicted (reduced proportionally)
• FEV1/FVC: Normal or elevated (≥0.70)
• TLC: Reduced (if lung volumes measured)

Common restrictive diseases:

Pulmonary fibrosis (ILD):

• Restrictive pattern: Reduced lung volumes
• Decreased DLCO: Impaired gas exchange
• CT diagnosis: Honeycombing, fibrosis
• Progressive: Declining lung function

Sarcoidosis:

• Restrictive pattern: Variable severity
• Hilar adenopathy: On chest X-ray
• Biopsy: May be needed for diagnosis

Chest wall disease:

• Kyphoscoliosis: Spinal deformity
• Obesity: Can cause restriction
• Neuromuscular weakness: Weak respiratory muscles

Mixed Obstructive-Restrictive Pattern

Mixed pattern:

• FEV1/FVC: <0.70 (obstructive component)
• FVC: <80% predicted (restrictive component)
• FEV1: Significantly reduced

Causes of mixed pattern:

• COPD + pulmonary fibrosis: Combined diseases
• Chronic asthma: With lung remodeling
• Cystic fibrosis: Both obstruction and restriction
• Long-standing disease: End-stage changes

COPD Severity (GOLD Criteria)

COPD staging based on post-bronchodilator FEV1:

”

Note: COPD diagnosis requires FEV1/FVC <0.70 post-bronchodilator AND appropriate symptoms (chronic cough, sputum, dyspnea) PLUS risk factors (smoking, biomass fuel exposure).

Asthma Severity

Asthma severity based on symptoms and FEV1:

Asthma control:

• Well controlled: Normal FEV1, minimal symptoms
• Not well controlled: Reduced FEV1, increased symptoms
• Very poorly controlled: Significantly reduced FEV1, frequent symptoms

What Is Reversibility?

Reversibility testing assesses whether airflow obstruction improves after bronchodilator medication.

Significant reversibility:

• FEV1 increase: ≥12% AND ≥200 mL after bronchodilator
• Suggests: Asthma rather than COPD
• Treatment response: Predicts response to bronchodilators

Poor reversibility:

• FEV1 increase: <12% OR <200 mL after bronchodilator
• Suggests: COPD rather than asthma
• Fixed obstruction: Little improvement with bronchodilator

Clinical Implications

Reversible obstruction:

• Diagnosis: Asthma more likely
• Treatment: Bronchodilators will be effective
• Prognosis: Better than fixed obstruction
• Monitoring: Serial spirometry to track

Fixed obstruction:

• Diagnosis: COPD more likely
• Treatment: Bronchodilators still help but less
• Prognosis: Worse than reversible obstruction
• Monitoring: Serial spirometry to track progression

What's on Your Report?

Spirometry report typically includes:

1. Patient Information:

• Name, date of birth, sex, race, height
• Date of test, testing location

2. Test Quality:

• Number of acceptable maneuvers
• Reproducibility (two best FVCs within 150 mL)
• Start of test quality (no hesitation, no coughing)
• End of test quality (exhaled for ≥6 seconds)

3. Measured Values:

• FVC (L and % predicted)
• FEV1 (L and % predicted)
• FEV1/FVC ratio
• PEF (L/sec and % predicted)
• Other flow measurements (FEF25-75, etc.)

4. Predicted Values:

• Based on age, height, sex, race
• Reference equations used (NHANES III, GLI, etc.)
• Confidence intervals

5. Interpretation:

• Normal vs. abnormal
• Pattern (obstructive, restrictive, mixed)
• Severity
• Reversibility (if bronchodilator given)

6. Graphs:

• Flow-volume loop
• Volume-time curve

Reading the Flow-Volume Loop

Normal flow-volume loop:

• Rapid rise: To peak flow (PEF)
• Gradual decline: As exhalation continues
• Concave shape: Curving downward (not straight line)
• Returns to zero: At end of exhalation

Obstructive pattern:

• Concave (scooped) appearance: Due to reduced airflow
• Reduced peak flow: Lower PEF
• May not return to zero: If air trapping present

Restrictive pattern:

• Narrower loop: Reduced lung capacity
• Normal shape: Just smaller
• Peak flow may be reduced: But shape preserved

What Does "Percent Predicted" Mean?

Percent predicted compares your results to what's expected for a healthy person similar to you.

Factors affecting predicted values:

• Age: Lung function peaks around age 20-25, then declines
• Height: Taller people have larger lungs
• Sex: Men generally have larger lungs than women
• Race/ethnicity: Some populations have different predicted values

Example:

• FVC 3.0 L (80% predicted): Your FVC is 80% of what's predicted
• FEV1 2.4 L (75% predicted): Your FEV1 is 75% of what's predicted

80% rule:

• ≥80% predicted: Generally considered normal
• <80% predicted: Generally considered abnormal

What Is the FEV1/FVC Ratio and Why Is It Important?

FEV1/FVC ratio is the most important value for detecting obstructive lung disease.

Why it matters:

• Detects obstruction: Ratio <0.70 = obstruction
• Distinguishes obstruction vs. restriction:
  • Obstruction: Reduced ratio
  • Restriction: Normal or elevated ratio
• COPD diagnosis: FEV1/FVC <0.70 is diagnostic criterion

Normal aging effect:

• FEV1 declines faster than FVC with aging
• Ratio decreases slightly with age
• But stays >0.70: In healthy aging

What If My Spirometry Is Normal But I Still Have Symptoms?

Normal spirometry doesn't rule out all lung disease:

Possible explanations:

1. Intermittent symptoms:

• Asthma: May be normal between symptoms
• Exercise-induced: Only abnormal with exercise
• Occupational: Only abnormal after exposure

2. Early disease:

• Mild disease: May not show on spirometry
• Early asthma: Normal between episodes
• Early ILD: May show restriction first

3. Extra-pulmonary causes:

• Vocal cord dysfunction: Throat problem, not lungs
• Deconditioning: Poor fitness, not lung disease
• Anxiety: Hyperventilation syndrome
• Gastroesophageal reflux: Can cause respiratory symptoms

4. Other tests needed:

• Chest X-ray or CT: Look for structural problems
• Bronchoprovocation: Methacholine challenge for asthma
• Ambulatory PFT: Home monitoring
• Lung volumes: If restriction suspected
• DLCO: If gas exchange problem suspected
• FENO: Fractional exhaled nitric oxide for eosinophilic inflammation

What Do FEF25-75 and Other Flow Measurements Mean?

FEF25-75 (Forced Expiratory Flow 25-75%) is the average flow rate during the middle half of the FVC.

What it measures:

• Small airways: Flow in smaller airways
• Early obstruction: May be abnormal before FEV1 reduced
• Sensitive but not specific: Can be abnormal in healthy people

Other flow measurements:

• FEFmax (Maximum flow): Same as PEF
• FEF50%: Flow at 50% of FVC
• FEF75%: Flow at 75% of FVC (small airways)

Clinical use:

• Early detection: May show small airway dysfunction
• Monitoring: Track early disease
• Not essential: For most diagnoses (FEV1, FVC, ratio most important)

What Is "Air Trapping" on Spirometry?

Air trapping occurs when air gets stuck in the lungs and can't be exhaled.

Signs on spirometry:

• Slow rise to plateau: Volume-time curve doesn't return to baseline quickly
• Increased FVC: After bronchodilator (more air can be exhaled)
• Reduced FVC initially: With improved FVC after bronchodilator

Causes of air trapping:

• COPD: Most common cause
• Asthma: During exacerbation
• Bronchiolitis: Small airway inflammation

Clinical significance:

• Hyperinflation: Lungs over-inflated
• Flattened diaphragm: On chest X-ray
• Dyspnea: Shortness of breath

Why Repeat Spirometry?

Serial spirometry tracks lung function over time:

Asthma monitoring:

• Diagnosis confirmation: Variability supports diagnosis
• Control assessment: FEV1 predicts exacerbation risk
• Treatment response: Is therapy working?
• Exacerbation prediction: Declining FEV1 predicts problems

COPD progression:

• Rate of decline: FEV1 decline over time
• Prognosis: Faster decline = worse prognosis
• Treatment effect: Does therapy slow decline?
• Exacerbation frequency: Correlates with FEV1

Occupational monitoring:

• Baseline: Before starting job
• Serial testing: Annual or periodic
• Early detection: Of occupational lung disease
• Disability assessment: Functional impairment

Treatment monitoring:

• Biologics: For severe asthma
• Bronchodilators: COPD therapy response
• Steroid taper: Maintaining lung function?

How Often Should Spirometry Be Repeated?

Frequency depends on clinical situation:

Asthma:

• At diagnosis: Establish baseline
• After treatment change: 4-6 weeks later
• Poor control: Repeat to assess
• Stable: Every 1-2 years

COPD:

• At diagnosis: Establish baseline
• After exacerbation: When recovered
• Stable: Every 1-2 years
• Pre-operative: Before surgery

Occupational monitoring:

• Baseline: Before exposure
• Periodic: Annually for asbestos, silica
• Symptoms: If symptoms develop

Follow your doctor's recommendations for monitoring frequency.

Understanding your spirometry results helps you understand your lung function and any respiratory disease you may have. The key measurements—FVC, FEV1, and FEV1/FVC ratio—provide essential information for diagnosing and managing asthma, COPD, and other respiratory conditions.

Remember that spirometry results must be interpreted in the context of your symptoms, physical examination, and other tests. Normal spirometry doesn't rule out all lung disease, and abnormal spirometry doesn't always indicate severe disease. Work with your healthcare provider to understand what your results mean for you and to develop an appropriate treatment plan if lung disease is detected.

Serial spirometry monitoring is essential for tracking disease progression and treatment response over time. Keep track of your results and ask questions about changes you don't understand.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment recommendations.

Sources:

• American Thoracic Society (ATS). "Spirometry Interpretation and Performance." 2024.
• American Lung Association. "Understanding Spirometry Results." 2024.
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). "COPD Diagnosis, Assessment, and Treatment." 2023.
• Mayo Clinic. "Pulmonary Function Tests: Understanding Your Results." 2024.